These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Episodes of ST-segment depression is related to changes in ambulatory blood pressure and heart rate in intermittent claudication. Svensson P; Niklasson U; Ostergren J J Intern Med; 2001 Nov; 250(5):398-405. PubMed ID: 11887974 [TBL] [Abstract][Full Text] [Related]
9. Alcohol septal ablation in hypertrophic cardiomyopathy utilizing a longitudinal 17-year study (mean 10.8). Observation follow-ups taken at a single medical centre. Wojtarowicz A; Kornacewicz-Jach Z Cardiol J; 2017; 24(2):125-130. PubMed ID: 27734458 [TBL] [Abstract][Full Text] [Related]
10. Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy. Kuhn H; Gietzen FH; Leuner C; Schäfers M; Schober O; Strunk-Müller C; Obergassel L; Freick M; Gockel B; Lieder F; Raute-Kreinsen U Z Kardiol; 2000; 89 Suppl 4():IV41-54. PubMed ID: 10810776 [TBL] [Abstract][Full Text] [Related]
11. [Comparative study of the effects of verapamil and propranolol therapy in 16 cases of obstructive hypertrophic myocardiopathy]. Cosnay P; Fauchier JP; Lang M; Casset D; Raynaud P; Lavigne G; Itti R Arch Mal Coeur Vaiss; 1987 Mar; 80(3):346-55. PubMed ID: 3113357 [TBL] [Abstract][Full Text] [Related]
12. Attenuation of biventricular pressure gradients by cibenzo-line in an 18-year-old patient with hypertrophic obstructive cardiomyopathy. Hiasa G; Hamada M; Shigematsu Y; Hara Y; Ohtsuka T; Ogimoto A; Saeki H; Suzuki J; Matsunaka T; Hamada H; Okura T; Hiwada K Circ J; 2002 Dec; 66(12):1173-5. PubMed ID: 12499627 [TBL] [Abstract][Full Text] [Related]
13. [Echocardiographic and hemodynamic studies on the influence of verapamil in hypertrophic obstructive cardiomyopathy (author's transl)]. Schmid P; Pavek P; Klein W Z Kardiol; 1979 Feb; 68(2):89-92. PubMed ID: 570768 [TBL] [Abstract][Full Text] [Related]